vs
BIOCRYST PHARMACEUTICALS INC（BCRX）与Ryman Hospitality Properties, Inc.（RHP）财务数据对比。点击上方公司名可切换其他公司
Ryman Hospitality Properties, Inc.的季度营收约是BIOCRYST PHARMACEUTICALS INC的1.8倍（$737.8M vs $406.6M），BIOCRYST PHARMACEUTICALS INC净利率更高（60.5% vs 10.1%，领先50.4%），BIOCRYST PHARMACEUTICALS INC同比增速更快（209.1% vs 13.9%），BIOCRYST PHARMACEUTICALS INC自由现金流更多（$291.2M vs $58.5M），过去两年BIOCRYST PHARMACEUTICALS INC的营收复合增速更高（109.4% vs 18.2%）
BioCryst Pharmaceuticals是一家总部位于美国北卡罗来纳州达勒姆的制药企业，属于后期发展阶段的生物科技公司，聚焦于治疗罕见重症的口服药物研发。其研发的抗病毒药物帕拉米韦（商品名Rapivab）于2014年12月获得美国FDA批准，此后也陆续在日本、韩国与中国获批上市。
莱曼酒店地产是一家主营酒店、度假村、娱乐及媒体业务的企业，得名于旗下位于田纳西州纳什维尔的国家历史地标莱曼礼堂。公司历史可追溯至曾为俄克拉荷马出版公司子公司时期，1983年收购WSM公司后奠定现代业务基础，同时将知名演出IP大奥普里等核心资产纳入麾下。
BCRX vs RHP — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $406.6M | $737.8M |
| 净利润 | $245.8M | $74.5M |
| 毛利率 | 97.7% | 41.4% |
| 营业利润率 | 64.0% | 19.4% |
| 净利率 | 60.5% | 10.1% |
| 营收同比 | 209.1% | 13.9% |
| 净利润同比 | 1017.5% | 3.0% |
| 每股收益（稀释后） | $1.13 | $1.12 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $406.6M | $737.8M | ||
| Q3 25 | $159.4M | $592.5M | ||
| Q2 25 | $163.4M | $659.5M | ||
| Q1 25 | $145.5M | $587.3M | ||
| Q4 24 | $131.5M | $647.6M | ||
| Q3 24 | $117.1M | $550.0M | ||
| Q2 24 | $109.3M | $613.3M | ||
| Q1 24 | $92.8M | $528.3M |
| Q4 25 | $245.8M | $74.5M | ||
| Q3 25 | $12.9M | $34.9M | ||
| Q2 25 | $5.1M | $71.8M | ||
| Q1 25 | $32.0K | $63.0M | ||
| Q4 24 | $-26.8M | $72.3M | ||
| Q3 24 | $-14.0M | $59.0M | ||
| Q2 24 | $-12.7M | $100.8M | ||
| Q1 24 | $-35.4M | $42.8M |
| Q4 25 | 97.7% | 41.4% | ||
| Q3 25 | 98.6% | 40.9% | ||
| Q2 25 | 98.3% | 49.7% | ||
| Q1 25 | 96.9% | 44.4% | ||
| Q4 24 | 95.4% | 40.4% | ||
| Q3 24 | 97.3% | 43.1% | ||
| Q2 24 | 98.4% | 48.4% | ||
| Q1 24 | 98.6% | 41.5% |
| Q4 25 | 64.0% | 19.4% | ||
| Q3 25 | 18.6% | 15.0% | ||
| Q2 25 | 18.2% | 21.1% | ||
| Q1 25 | 14.6% | 19.8% | ||
| Q4 24 | -3.4% | 18.6% | ||
| Q3 24 | 6.6% | 19.3% | ||
| Q2 24 | 8.0% | 27.4% | ||
| Q1 24 | -15.6% | 18.2% |
| Q4 25 | 60.5% | 10.1% | ||
| Q3 25 | 8.1% | 5.9% | ||
| Q2 25 | 3.1% | 10.9% | ||
| Q1 25 | 0.0% | 10.7% | ||
| Q4 24 | -20.4% | 11.2% | ||
| Q3 24 | -12.0% | 10.7% | ||
| Q2 24 | -11.6% | 16.4% | ||
| Q1 24 | -38.1% | 8.1% |
| Q4 25 | $1.13 | $1.12 | ||
| Q3 25 | $0.06 | $0.53 | ||
| Q2 25 | $0.02 | $1.12 | ||
| Q1 25 | $0.00 | $1.00 | ||
| Q4 24 | $-0.13 | $1.12 | ||
| Q3 24 | $-0.07 | $0.94 | ||
| Q2 24 | $-0.06 | $1.65 | ||
| Q1 24 | $-0.17 | $0.67 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $274.7M | $471.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-119.2M | $750.2M |
| 总资产 | $514.2M | $6.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | $274.7M | $471.4M | ||
| Q3 25 | $212.9M | $483.3M | ||
| Q2 25 | $260.0M | $420.6M | ||
| Q1 25 | $295.1M | $413.9M | ||
| Q4 24 | $320.9M | $477.7M | ||
| Q3 24 | $96.8M | $534.9M | ||
| Q2 24 | $78.4M | $498.4M | ||
| Q1 24 | $84.3M | $465.3M |
| Q4 25 | $-119.2M | $750.2M | ||
| Q3 25 | $-387.9M | $758.5M | ||
| Q2 25 | $-421.6M | $800.4M | ||
| Q1 25 | $-451.9M | $531.5M | ||
| Q4 24 | $-475.9M | $549.0M | ||
| Q3 24 | $-468.6M | $551.9M | ||
| Q2 24 | $-475.6M | $562.6M | ||
| Q1 24 | $-476.2M | $529.9M |
| Q4 25 | $514.2M | $6.2B | ||
| Q3 25 | $446.4M | $6.2B | ||
| Q2 25 | $457.2M | $6.1B | ||
| Q1 25 | $480.0M | $5.2B | ||
| Q4 24 | $490.4M | $5.2B | ||
| Q3 24 | $491.3M | $5.2B | ||
| Q2 24 | $472.4M | $5.1B | ||
| Q1 24 | $467.9M | $5.1B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $292.0M | $164.7M |
| 自由现金流经营现金流 - 资本支出 | $291.2M | $58.5M |
| 自由现金流率自由现金流/营收 | 71.6% | 7.9% |
| 资本支出强度资本支出/营收 | 0.2% | 14.4% |
| 现金转化率经营现金流/净利润 | 1.19× | 2.21× |
| 过去12个月自由现金流最近4个季度 | $344.9M | $232.4M |
8季度趋势，按日历期对齐
| Q4 25 | $292.0M | $164.7M | ||
| Q3 25 | $41.6M | $205.2M | ||
| Q2 25 | $41.3M | $122.5M | ||
| Q1 25 | $-27.5M | $98.2M | ||
| Q4 24 | $-5.2M | $166.6M | ||
| Q3 24 | $8.2M | $218.1M | ||
| Q2 24 | $-1.4M | $184.3M | ||
| Q1 24 | $-53.7M | $7.5M |
| Q4 25 | $291.2M | $58.5M | ||
| Q3 25 | $40.3M | $135.4M | ||
| Q2 25 | $41.1M | $53.0M | ||
| Q1 25 | $-27.7M | $-14.5M | ||
| Q4 24 | $-5.9M | $76.0M | ||
| Q3 24 | $8.2M | $85.7M | ||
| Q2 24 | $-1.5M | $78.8M | ||
| Q1 24 | $-53.9M | $-72.0M |
| Q4 25 | 71.6% | 7.9% | ||
| Q3 25 | 25.3% | 22.9% | ||
| Q2 25 | 25.2% | 8.0% | ||
| Q1 25 | -19.0% | -2.5% | ||
| Q4 24 | -4.5% | 11.7% | ||
| Q3 24 | 7.0% | 15.6% | ||
| Q2 24 | -1.4% | 12.9% | ||
| Q1 24 | -58.1% | -13.6% |
| Q4 25 | 0.2% | 14.4% | ||
| Q3 25 | 0.8% | 11.8% | ||
| Q2 25 | 0.1% | 10.5% | ||
| Q1 25 | 0.1% | 19.2% | ||
| Q4 24 | 0.5% | 14.0% | ||
| Q3 24 | 0.1% | 24.1% | ||
| Q2 24 | 0.1% | 17.2% | ||
| Q1 24 | 0.3% | 15.0% |
| Q4 25 | 1.19× | 2.21× | ||
| Q3 25 | 3.23× | 5.88× | ||
| Q2 25 | 8.12× | 1.71× | ||
| Q1 25 | -859.91× | 1.56× | ||
| Q4 24 | — | 2.30× | ||
| Q3 24 | — | 3.70× | ||
| Q2 24 | — | 1.83× | ||
| Q1 24 | — | 0.17× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BCRX
暂无分部数据
RHP
| Hotel Other | $157.7M | 21% |
| Gaylord Opryland | $147.4M | 20% |
| Hotel Transient Rooms | $93.6M | 13% |
| Hotel Food And Beverage Outlets | $92.2M | 12% |
| Gaylord Palms | $88.2M | 12% |
| Jw Marriott Hill Country | $53.7M | 7% |
| Entertainment Admissions And Ticketing | $43.1M | 6% |
| Entertainment Food And Beverage | $38.1M | 5% |
| Entertainment Retail And Other | $28.3M | 4% |
| Ac Hotel | $2.4M | 0% |
